Regeneron Pharmaceuticals (REGN) Net Cash Flow Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 89.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -13.44% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 33.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -29.82% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 32.17% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.82% |
| Dec 31, 2025 | 53.05% |
| Sep 30, 2025 | 72.98% |
| Jun 30, 2025 | -187.72% |
| Mar 31, 2025 | 9.38% |
| Dec 31, 2024 | 42.18% |
| Sep 30, 2024 | -60.66% |
| Jun 30, 2024 | -45.40% |
| Mar 31, 2024 | 44.77% |
| Dec 31, 2023 | -2.38% |
| Sep 30, 2023 | 35.79% |
| Jun 30, 2023 | -109.24% |
| Mar 31, 2023 | 11.09% |
| Dec 31, 2022 | -54.03% |
| Sep 30, 2022 | -34.31% |
| Jun 30, 2022 | 27.54% |
| Mar 31, 2022 | 24.18% |
| Dec 31, 2021 | -50.95% |
| Sep 30, 2021 | 100.05% |
| Jun 30, 2021 | 102.01% |
| Mar 31, 2021 | -78.21% |
| Dec 31, 2020 | 210.98% |
| Sep 30, 2020 | -120.74% |
| Jun 30, 2020 | -47.39% |
| Mar 31, 2020 | 28.76% |
| Dec 31, 2019 | 37.95% |
| Sep 30, 2019 | 7.40% |
| Jun 30, 2019 | -160.49% |
| Mar 31, 2019 | 46.98% |
| Dec 31, 2018 | 34.97% |
| Sep 30, 2018 | -13.67% |
| Jun 30, 2018 | 4.69% |
| Mar 31, 2018 | 51.37% |
| Dec 31, 2017 | 112.03% |
| Sep 30, 2017 | 0.95% |
| Jun 30, 2017 | -35.50% |
| Mar 31, 2017 | 79.15% |
| Dec 31, 2016 | -49.90% |
| Sep 30, 2016 | 62.76% |
| Jun 30, 2016 | -40.55% |
| Mar 31, 2016 | -60.11% |
| Dec 31, 2015 | 11.56% |
| Sep 30, 2015 | 91.17% |
| Jun 30, 2015 | 19.22% |
| Mar 31, 2015 | -16.51% |
| Dec 31, 2014 | -80.16% |
| Sep 30, 2014 | 43.72% |
| Jun 30, 2014 | 5.15% |
| Mar 31, 2014 | -73.63% |
| Dec 31, 2013 | 48.59% |
| Sep 30, 2013 | -36.72% |
| Jun 30, 2013 | 241.72% |
| Mar 31, 2013 | 17.77% |
| Dec 31, 2012 | 65.99% |
| Sep 30, 2012 | -35.79% |